Developing an education platform for the stem cell industry

We promised we’d keep you updated on our plans, and it’s high time we did.

Wideacademy are to launch an alpha version of an innovative Software as a Service (‘SaS’) platform to deliver authentic, factual and trustworthy content on stem cell treatments and life sciences. We’re currently working with our technical partners for a commercial launch of the platform in the first quarter of next year, which will:

· Inform the medical industry of the benefits of stem cell treatment;

· Educate and inform consumers on stem cell innovation and best practice; and

· Partner with enterprise, within both the stem cell and insurance industry, to create training and digital resources.

It will be unique, purpose built and intelligent technology, created to enhance knowledge sharing, personal learning journeys, and continuous professional development. It will have contextual search functionality, meaning it is responsive and can deliver personalised content relevant to each user’s interest and/or requirement. Combining free-to-access educational areas with paid for premium digital tools and Artificial Intelligence, it will have a three-part structure and monetisation strategy:

· Sponsorship:

For an estimated annual membership cost starting at £120 per doctor / medical professional, sponsors will be able to gain access to the Premium Platform, which includes high-end content, digital tools, peer-to-peer collaboration, AI and dashboard reporting in support of stem cell innovation and education.

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    X
    LinkedIn
    WideCells Group PLC

    More articles like this

    WideCells Group PLC

    Umbilical blood injects new life into 8-month-old baby

    An 8-month-old girl who had severe combined immune deficiency (SCID) underwent a successful hematopoietic stem cell transplant surgery in Shanghai. The stem cell was taken from umbilical cord blood. Widecells Group PLC (LON:WDC) are leading a

    WideCells Group PLC

    Leukaemia: A Guide To The Cancer Of The Blood

    It is not hereditary, and it is not contagious. It is, however, one of the diseases that kills more children than many others. The word ‘leukaemia’ refers to a group of cancers that spread through the

    WideCells Group PLC

    Autism Treated With Stem Cells

    Researchers at Duke University have utilized autologous (the patient’s own) stem cell infusions to promote increased connectivity in the brain that allowed for improved communication and language abilities in children with Autism Spectrum Disorder (ASD). The

    WideCells Group PLC

    Cord blood banking industry expected to grow

    The list of decisions for new parents already seems endless but it continues to grow as new advances in medicine and technology open new doors for healthcare. Many private companies offer services for collecting and storing